Author: da Silva V.O. Borja-Cabrera G.P. Correia Pontes N.N. de Souza E.P. Luz K.G. Palatnik M. Palatnik de Sousa C.B.
Publisher: Elsevier
ISSN: 0264-410X
Source: Vaccine, Vol.19, Iss.9, 2000-12, pp. : 1082-1092
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
By Borja-Cabrera G.P. Correia Pontes N.N. da Silva V.O. Paraguai de Souza E. Santos W.R. Gomes E.M. Luz K.G. Palatnik M. Palatnik de Sousa C.B.
Vaccine, Vol. 20, Iss. 27, 2002-09 ,pp. :
By Sherwood J.A. Copeland R.S. Taylor K.A. Abok K. Oloo A.J. Were J.B.O. Strickland G.T. Gordon D.M. Ballou W.R. Bales J.D. Wirtz R.A. Wittes J. Gross M. J. U.Q. Cryz S.J. Oster C.N. Roberts C.R. Sadoff J.C.
Vaccine, Vol. 14, Iss. 8, 1996-06 ,pp. :
By Richie E.E. Punjabi N.H.N.H. Sidharta Y.Y. Peetosutan K.K. Sukandar M.M. Wasserman S.S.S.S. Lesmana M.M. Wangsasaputra F.F. Pandam S.S. Levine M.M.M.M. O'Hanley P.P. Cryz S.J.S.J. Simanjuntak C.H.C.H.
Vaccine, Vol. 18, Iss. 22, 2000-05 ,pp. :
Some important issues in the planning of phase III HIV vaccine efficacy trials
By Boily M.-C. Masse B.R. Desai K. Alary M. Anderson R.M.
Vaccine, Vol. 17, Iss. 7, 1999-02 ,pp. :